Form 4 Filing for Aurinia Pharmaceuticals Inc.

Jeffrey Allen Bailey, a director at Aurinia Pharmaceuticals Inc. (AUPH), acquired 23,931 stock options on June 4, 2026. These options, with an exercise price of $15.67, are exercisable until June 4, 2036. The options vest one year from the date of grant. This transaction, reported on Form 4, indicates a change in the director's holdings. The underlying security for these options is Aurinia Pharmaceuticals Inc. Common Shares. Mr. Bailey currently holds no shares directly, but following this transaction, he holds 23,931 options. The reporting owner's address is in Edmonton, Alberta, Canada.